Caption Management, LLC Incyte Corp Call Options Transaction History

Caption Management, LLC

13 transactions

Quarter	Operation	Price Per call	calls change	calls Held
Q2 2024 Aug 14, 2024	BUY	$51.18 - $63.75 $5.37 Million - $6.69 Million	105,000 New	105,000 $6.37 Million
Q3 2023 Nov 14, 2023	BUY	$57.77 - $65.93 $1.73 Million - $1.98 Million	30,000 New	30,000 $1.73 Million
Q3 2022 Nov 14, 2022	BUY	$66.18 - $82.86 $1.99 Million - $2.49 Million	30,000 New	30,000 $2 Million
Q2 2022 Aug 15, 2022	SELL	$66.18 - $83.18 $2.32 Million - $2.91 Million	-35,000 Closed	0 $0
Q1 2022 May 13, 2022	BUY	$66.02 - $79.71 $330,100 - $398,549	5,000 Added 16.67%	35,000 $2.78 Million
Q4 2021 Feb 11, 2022	SELL	$63.34 - $74.11 $10.7 Million - $12.5 Million	-169,000 Reduced 84.92%	30,000 $2.2 Million
Q3 2021 Nov 12, 2021	SELL	$68.67 - $84.02 $3.85 Million - $4.71 Million	-56,000 Reduced 21.96%	199,000 $13.7 Million
Q2 2021 Aug 16, 2021	BUY	$79.87 - $87.53 $17.2 Million - $18.8 Million	215,000 Added 537.5%	255,000 $21.5 Million
Q1 2021 May 17, 2021	SELL	$76.02 - $100.5 $4.77 Million - $6.31 Million	-62,800 Reduced 61.09%	40,000 $3.25 Million
Q4 2019 Feb 13, 2020	BUY	$73.04 - $95.72 $4.02 Million - $5.26 Million	55,000 Added 115.06%	102,800 $8.98 Million
Q3 2019 Nov 14, 2019	SELL	$72.82 - $86.52 $1.09 Million - $1.3 Million	-15,000 Reduced 23.89%	47,800 $3.55 Million
Q2 2019 Aug 13, 2019	BUY	$73.52 - $88.7 $1.1 Million - $1.33 Million	15,000 Added 31.38%	62,800 $5.34 Million
Q1 2019 May 14, 2019	BUY	$63.56 - $88.17 $3.04 Million - $4.21 Million	47,800 New	47,800 $4.11 Million

644

186M

714K

557K

Ticker INCY
Exchange NASDAQ
Sector Healthcare
Industry Biotechnology
Shares Outstandng 222,431,008
Market Cap $16.8B
Description
Incyte Corporation, a biopharmaceutical company, focuses on the discovery, development, and commercialization of proprietary therapeutics in the United States and internationally. The company offers JAKAFI, a drug for the treatment of myelofibrosis and polycythemia vera; PEMAZYRE, a fibroblast growth factor receptor kinase inhibitor that act as ...

Get notified when there are updates to the investment portfolio of Caption Management, LLC, based on Form 13F filings with the SEC.

Stay updated on Caption Management, LLC with notifications on news.